Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cyclophosphamide (cytoxan) (1 trial)
docetaxel (taxotere) (1 trial)
paclitaxel (taxol) (1 trial)
Breast Neoplasms (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Trials (2 total)
Trial APIs (3 total)